Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study ; volume:22 ; number:1 ; day:25 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (25.3.2023), 1-14, 12.2023
- Creator
-
Piccini, Sara
Favacchio, Giuseppe
Panico, Cristina
Morenghi, Emanuela
Folli, Franco
Mazziotti, Gherardo
Lania, Andrea Gerardo
Mirani, Marco
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-023-01800-z
- URN
-
urn:nbn:de:101:1-2023081310442912115043
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Piccini, Sara
- Favacchio, Giuseppe
- Panico, Cristina
- Morenghi, Emanuela
- Folli, Franco
- Mazziotti, Gherardo
- Lania, Andrea Gerardo
- Mirani, Marco
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Time-Dependent Effects of Unemployment Benefits
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Time-Dependent Effects of Unemployment Benefits
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Time-Dependent Effects of Unemployment Benefits
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence